We’ve all seen the Viagra commercials full of happy men, but where are the commercials full of ecstatic, sexually satisfied women? Those could be coming soon to a TV near you.
There is a new drug in the clinical trial phase that is expected to improve sexual desire in women. The magical sexual pill is called Lybrido.
The pill is supposed to treat hypoactive sexual desire disorder (HSDD), according to Clinicaltrials.gov. HSDD is actually considered a mental disorder and is included in the Diagnostic and Statistical Manual of Mental Disorders (DSM IV-TR).
It’s defined as “a deficiency or absence of sexual fantasies and desire for sexual activity,” and “the disturbance must cause marked distress or interpersonal difficulty,” according to the DSM.
An article on the pill in The New York Times suggested that even if pills like Viagra and the future Lybrido both treat sexual disorders, the causes of sexual problems vary. Viagra helps a physical problem of erectile dysfunction, whereas Lybrido focuses on changing the brain in a way to improve desire and drive.
Experts explore how women’s brains and mental health could be impacted by a future sexual desire drug like Lybrido, and look into the connection between sexual desire and mental health.
Dr. Sue Decotiis, board-certified in internal medicine, specializes in hormone replacement therapy and said in an email that women’s sexual desire and mental health are closely related.
“If a woman is depressed, anxious or stressed, her libido and/or capacity to reach orgasm will decline,” Decotiis said.
She said that on the opposite end of the spectrum, women with bipolar disorder can sometimes experience periods of “reckless sexual behavior.”
In regards to sexual dysfunction, Decotiis suggested that it can sometimes be related to low testosterone. This is especially true for women on birth control pills and for women who are stressed. Therefore she recommended making sure hormonal imbalances aren’t part of the problem.
“Lybrido may indeed prove itself to be a valuable tool in the treatment of HSDD,” she said.